L. Becker Hewes, CHIEF MEDICAL OFFICER at Blueprint Medicines Corp (BPMC), sold 20,190 shares at $87.98 ($1.8M) on 2025-03-06, disclosed to the SEC on 2025-03-07.
Scheduled sale ($1.8M) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.80 | 4,863 | $432K | 24.2% |
| 2 | $88.80 | 4,863 | $432K | 24.2% |
| 3 | $87.42 | 2,691 | $235K | 13.2% |
| 4 | $87.42 | 2,691 | $235K | 13.2% |
| 5 | $87.98 | 2,541 | $224K | 12.6% |
| 6 | $87.98 | 2,541 |
| $224K |
| 12.6% |
| Total | $88.23 avg | 20,190 | $1.8M | 100% |
| Filing → |
| BPMC | SELL | 2024-03-11 | $562K | — | Filing → |
| BPMC | SELL | 2023-06-07 | $146K | — | Filing → |
| BPMC | SELL | 2023-03-08 | $136K | — | Filing → |